The results of the investigation are inconclusive since the reported device was not returned for analysis.Based on the information received, the cause of the reported event could not be conclusively determined.The device history record for this oad lot number has been reviewed.No issues or discrepancies were noted during this review that would have contributed to the reported event.The device met material, assembly, and quality control requirements.The stealth peripheral orbital atherectomy device instructions for use states that perforation is a possible adverse event which can occur with use of the stealth peripheral orbital atherectomy device.(b)(4).
|
During a procedure, a perforation occurred after use of the stealth peripheral orbital atherectomy device (oad) and balloon angioplasty.The heavily calcified, complete total occluded (cto) target lesion was located in the mid-anterior tibial artery (at) and was accessed via a pedal approach.The lesion was treated with orbital atherectomy, and a perforation occurred when balloon angioplasty was performed.The procedure was delayed approximately 45 minutes while the perforation was treated with additional balloon angioplasty.In the physician's opinion, it was unknown if the orbital atherectomy or balloon angioplasty caused the perforation.The patient was fine following the procedure.
|